Back to top
more

OptimizeRx (OPRX)

(Real Time Quote from BATS)

$6.60 USD

6.60
41,604

-0.03 (-0.45%)

Updated Oct 14, 2024 02:32 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (78 out of 250)

Industry: Computer - Software

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Will EchoStar's Collaboration With Connected Boost SATS Stock?

by Zacks Equity Research

SATS teams up with Connected to reshape the landscape of off-grid connectivity by launching a cutting-edge Connected One solution.

Will Grid Edge Essentials Solution Launch Benefit ITRI Stock?

by Zacks Equity Research

To address key challenges in the modern utility landscape, Itron introduces the Grid Edge Essentials solution, redefining the future of utility management.

LVO Amends TSLA Partnership: Can Streaming Upgrade Boost the Stock?

by Zacks Equity Research

LiveOne's amended partnership with Tesla is set to transform streaming services while impacting its financial outlook for fiscal 2025

Thermon Boosts Portfolio With F.A.T.I. Buyout: Will Stock Gain?

by Zacks Equity Research

THR augments production capacity to meet rising demand for electrification and decarbonization solutions with F.A.T.I. acquisition

SAP Reportedly Faces Expanded DOJ Probe for Alleged Price Fixing

by Zacks Equity Research

SAP and Carahsoft now face expanded probe as DOJ investigates their collaboration with nearly 100 other government agencies

FUJIY Boosts Semiconductor Materials Business With 20B Yen Investment

by Zacks Equity Research

FUJIFILM augments its facilities in Shizuoka and Oita, Japan, with 20 billion yen investment to boost its semiconductor materials business

OptimizeRx (OPRX) Moves 5.4% Higher: Will This Strength Last?

by Zacks Equity Research

OptimizeRx (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

NetApp Strengthens Partnership With Google Cloud: Stock to Benefit?

by Zacks Equity Research

The integration of NTAP's intelligent data infrastructure with Google Cloud is aimed at fostering AI advancement

Sonos Focuses on Regaining Customer Trust Post App Redesign Debacle

by Zacks Equity Research

SONO seeks to restore customer confidence by announcing seven new pledges following a review of its Sonos app launch challenges from May

DSGX's Routing Solution Adopted by Mitchell Companies: Stock to Gain?

by Zacks Equity Research

Mitchell Companies is utilizing Descartes' route planning and execution platform to enhance distribution efficiency and maintain high delivery productivity.

Down -12.46% in 4 Weeks, Here's Why OptimizeRx (OPRX) Looks Ripe for a Turnaround

by Zacks Equity Research

The heavy selling pressure might have exhausted for OptimizeRx (OPRX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

OptimizeRx Corp. (OPRX) Tops Q2 Earnings Estimates

by Zacks Equity Research

OptimizeRx (OPRX) delivered earnings and revenue surprises of 128.57% and 8.10%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

NuScale Power (SMR) to Post Q2 Earnings: What's in Store?

by Zacks Equity Research

NuScale Power's (SMR) second-quarter 2024 performance is likely to reflect strong demand for electricity powering AI-supported data centers.

DigitalOcean (DOCN) to Post Q2 Earnings: What's in Store?

by Zacks Equity Research

DigitalOcean's (DOCN) second-quarter 2024 performance is likely to reflect the benefits of a robust product portfolio and the strong demand for its AI platform and cloud-based services.

Smith Micro Software, Inc. (SMSI) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Smith Micro Software (SMSI) delivered earnings and revenue surprises of -8.57% and 4.82%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

OptimizeRx (OPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Does OptimizeRx (OPRX) Have the Potential to Rally 34.78% as Wall Street Analysts Expect?

by Zacks Equity Research

The consensus price target hints at a 34.8% upside potential for OptimizeRx (OPRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Open Text (OTEX) Q3 Earnings Meet Estimates

by Zacks Equity Research

Open Text (OTEX) delivered earnings and revenue surprises of 0% and 1.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

After Plunging -22.84% in 4 Weeks, Here's Why the Trend Might Reverse for OptimizeRx (OPRX)

by Zacks Equity Research

OptimizeRx (OPRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX)

by Zacks Equity Research

OptimizeRx (OPRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Bruker (BRKR) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

Bruker (BRKR) delivered earnings and revenue surprises of 7.69% and 2.87%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

New Strong Buy Stocks for January 11th

by Zacks Equity Research

ADMA, ARQT, PHR, OPRX and PHG have been added to the Zacks Rank #1 (Strong Buy) List on January 11, 2024.

OptimizeRx Corp. (OPRX) Upgraded to Buy: What Does It Mean for the Stock?

by Zacks Equity Research

OptimizeRx Corp. (OPRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Wall Street Analysts Predict a 41.25% Upside in OptimizeRx Corp. (OPRX): Here's What You Should Know

by Zacks Equity Research

The consensus price target hints at a 41.3% upside potential for OptimizeRx Corp. (OPRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks.com featured highlights Freshpet, OptimizeRx and Pinterest

by Zacks Equity Research

Freshpet, OptimizeRx and Pinterest have been highlighted in this Screen of The Week article.